# Ernexa Therapeutics Inc.: Form 8-K, filed Oct 11, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2022-10-11
- Accepted by EDGAR: Oct 11, 2022, 08:30 ET
- Period: 2022-10-11
- Accession: 0001140361-22-036744
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122036744/brhc10042808_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122036744/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122036744/brhc10042808_8k.htm

Filed Oct 11, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-036744. Last ingested by Listed: Oct 30, 2026, 14:05 ET. No prices; not investment advice.